TY - JOUR
T1 - Characteristics of Fluoroquinolone-Resistant of Avian Pathogenic Escherichia coli Isolates in China
AU - Wang, Xiaoquan AU - Liu, Xiaowen AU - Wang, Yanhong
JO - Journal of Animal and Veterinary Advances
VL - 11
IS - 23
SP - 4406
EP - 4412
PY - 2012
DA - 2001/08/19
SN - 1680-5593
DO - javaa.2012.4406.4412
UR - https://makhillpublications.co/view-article.php?doi=javaa.2012.4406.4412
KW - Fluoroquinolone
KW -resistant
KW -avian pathogenic Escherichia coli
KW -nalicliuic acid
KW -China
AB - A total of 121 Avian Pathogenic Escherichia coli (APEC)
isolates recovered from diagnosed cases of avian colibacillosis from China during
2009 and 2011 were serotyped and examined for susceptibility to nalidixic acid
and 6 fluoroquinolones. About 23 different serotypes were determined by agglutination
using antisera and 078 (28/121), O143 (21/121) and O2 (15/121) were predominant
serotypes. APEC isolates displayed resistance to nalidixic acid (95.9%), norfloxacin
(95.0%), ciprofloxacin (94.2%), enrofloxacin (86.8%), levofloxacin (75.2%),
lomefloxacin (63.6%) and ofoxacin (61.2%), respectively. Single gyrA changes
(mainly Ser 83 to Leu) correlated with nalidixic acid MICs ≥32 μg mL-1.
The Asp87 changes (mainly Asp87 to Asn) in gyrA were associated with higher
ciprofloxacin MICs. ParC alterations comprised amino acid changes Ser 80 to
Ile, Ser 80 to Arg, Glu84 to Gly, Glu84 to Lys. The fluoroquinolone-resistant
strains for which nalidixic acid MICs were >256 μg mL-1 had
both gyrA sand parC QRDR point mutations. The fluoroquinolone-resistant isolates
had common point mutations in gyrA (Ser 83 to Leu, Asp87 to Asn) and parC (Ser80
to Ile). These strains for which ciprofloxacin MICs were >8 μg mL-1
had double gyrA mutations, accompanying with ParC alterations. Seven recent
isolates carried qnrS gene and three carried aac(6')-Ib-cr gene.
This suggests that the widespread mutations at position 83, 87 of gyrA and position
80 of parC were crucial for resistance to fluoroquinolone and showed significant
relation to the high-level fluoroquinolone resistance in APEC.
ER -